Veradigm | MDRX - Srodki Pieniężne I Ekwiwalent

Cena Akcji
4.58
Dzienna Zmiana
-0.07 -1.40%
Miesięcznie
1.78%
Rocznie
7.76%
Q1 Prognozy TE
4.44




Srodki Pieniężne I Ekwiwalent Zmiana Data
Alcidion AUD 11.8M 2.84M 2024-06
Ambu A/S DKK 735M 16M 2025-12
Amplifon EUR 237.31M 5.38M 2025-09
Cardinal Health USD 2.78B 1.82B 2025-12
Centene USD 17.89B 830M 2025-12
Charles River Laboratories USD 213.77M 6.67M 2025-12
Cigna USD 7.68B 1.65B 2025-12
Coloplast 911M 497M 2023-09
Computer Programs Systems USD 19.92M 7.64M 2025-09
Convatec Group USD 64.7M 32.2M 2024-12
CVS Health USD 8.45B 645M 2025-12
Diasorin EUR 173.08M 3.51M 2025-06
Elevance Health USD 9.49B 778M 2025-12
General Electric Aerospace USD 12.39B 109M 2025-12
Gulf Medical Proj AED 74.52M 101.52M 2025-03
Humana USD 4.2B 1.19B 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Maximus USD 137.59M 84.76M 2025-12
McKesson USD 2.96B 1.05B 2025-12
Med Life RON 185.35M 35.79M 2025-09
Molina Healthcare USD 4.25B 27M 2025-12
Omnicell USD 180.05M 218.95M 2025-09
Oriola-kd EUR 107.6M 13.9M 2025-09
Owens Minor USD 281.99M 249.15M 2025-12
Quest Diagnostics USD 420M 12M 2025-12
Rede D'or Sao Luiz BRL 5.53B 456.83M 2025-09
Siemens Healthineers EUR 2.37B 30M 2025-06
Sonova Holding CHF 413.9M 134.3M 2023-06
Supermax Corporation Bhd MYR 855.25M 11.02M 2025-09
UnitedHealth USD 28.12B 2.49B 2025-12
Veeva Systems USD 1.42B 238.9M 2025-12
Veradigm USD 492.6M 7.57M 2022-09
Xerox USD 479M 30M 2025-09